Modeling and validating three dimensional human normal cervix and cervical cancer tissues in vitro

Area of Science:

• Biomedical Engineering
• Cancer Research
• Tissue Engineering

Background:

• Three-dimensional in vitro systems offer a promising avenue for developing novel anticancer therapies.
• Existing models may not fully replicate the complexity of normal and cancerous cervical tissues.

Purpose of the Study:

• To engineer a functional three-dimensional (3-D) in vitro model representing both normal and cancerous cervical tissue.
• To validate the model's biological relevance by comparing it to in vivo tissue characteristics.

Main Methods:

• Utilized normal epithelial and cervical carcinoma cell lines to construct 3-D tissue models.
• Employed de-epidermised dermis (DED) as a scaffold for tissue engineering.
• Performed morphological analysis via hematoxylin and eosin staining and immunohistochemistry for cytokeratins and Mad1 protein expression.

Main Results:

• Hematoxylin and eosin staining revealed multi-layered epithelium in normal tissue and dysplastic changes in cancerous tissue models.
• Immunohistochemistry demonstrated distinct cytokeratin expression patterns (CK10, CK5, CK19) in normal versus cancerous models, mirroring in vivo tissues.
• Mad1 protein expression was observed in suprabasal cells of the cancerous model.

Conclusions:

• The engineered 3-D in vitro cervical tissue models exhibit stratified epithelial layers.
• These models successfully replicate the differentiation marker protein expression patterns found in corresponding in vivo normal and cancerous cervical tissues.
• The developed models serve as functional representations of normal and cancerous cervical tissue for research applications.